top of page

AZN

Astrazeneca plc - ADR

$67.91

+0.65 (+0.97%)

chg neg

quotes and stock data may be delayed 15 minutes

 My Notes

Only BPIQ Pro members can create company notes. Learn more here.

52 wk low

51.9

52 wk hi

71.09

Cash

$5.8 B

Burn Rate (Qtr)

N/A

Mkt Cap

$210.5b

Avg Volume

4,273,353

*cash/burn updated:

Q1 '22

Drug Pipeline

Click the button to see the updated pipeline

No drug found

We don't have any drug data for this company yet

Drug | Disease (links)

Stage (next event)

Catalyst Date

Drug Name

Indication

Phase

Event

Exp Date

A free account is required to see the catalyst dates, notes, and more!

Create Free Account Now

Loading Catalysts...

search in progress

Pipeline powered by

AZN

BPIQ_Logo_RGB-01.jpg

Company Profile

Driven by innovative science and our entrepreneurial culture, we are focused on the delivery of life-changing medicines that are fuelling growth and contributing value to patients and society.

Recent Posts

See what the community is saying - click to see full post.

Is Booster in China a Big Opp for Covid Vaccine Companies?

All Covid Vaccines May Have the Rare Blood-Clotting Side Effect

AZN - Vaccine hopes rise as Oxford jab prompts immune response among old as well as young adults

AZN - FDA authorizes restart of the COVID-19 AZD1222 vaccine US Phase III trial

AZN - SARS-CoV-2 vaccine, AZD1222, COVID-19 vaccine trials temporary pause

bottom of page